Sun, Mar 18, 2018
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Industry Updates

Lyxor launches M&A fund on its alternative UCITS platform

Monday, June 17, 2013
Opalesque Industry Update - Lyxor Asset Management (“Lyxor”) has announced the launch of the Lyxor / Tiedemann Arbitrage Strategy Fund (the “Fund”), a new UCITS-compliant vehicle, which is designed to give access to a pure merger arbitrage strategy in partnership with the hedge fund firm TIG Advisors, LLC* (“TIG”).

The Fund will benefit from TIG’s recognized merger arbitrage expertise supported by large deal experience, strong focus on research and high market convictions. The Fund’s investment strategy is to play arbitrage deals from both a long and a short perspective by investing in securities that are subject to special events in North America, Europe, Australia, South America and Asia. The investment team focuses on 0-30 day events within the merger arbitrage process and looks for wide spreads and complex deal opportunities relying on TIG’s deep research capabilities.

The current macro economic and financial landscape provides a robust environment for global merger arbitrage with:

- Cash reserves in corporate balance sheets at an extremely high level,
- Interest rates at historic lows,
- Global banking stabilization,
- Complex deals providing significantly better spread opportunities.

Mr. Drew Figdor, Portfolio Manager for the strategy at TIG since 1993, commented: “We look for complex mergers where our research can add value and are anticipating an uptick in mega-cap deals driven by the increased availability of funding, both for strategic buyers and private equity. “ The Fund, now passported in 6 countries, is available on Lyxor’s Alternative UCITS Platform in EUR, USD, JPY, CHF, GBP, SEK and NOK. Investors in the Fund will also benefit from the weekly liquidity and independent risk management provided by Lyxor.

press release


What do you think?

   Use "anonymous" as my name    |   Alert me via email on new comments   |   
Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Performance - Hedge fund mojo is back with investor hopes at six-year high, These hedge funds produce the most consistently great results[more]

    Hedge fund mojo is back with investor hopes at six-year high From Hedge funds on the heels of a surprisingly strong performance in 2017 are raising hopes for an encore. Investors expect their managers to return 8.5 percent in 2018, according to a Credit Suisse Group AG sur

  2. Investing - Hedge funds amass big bets against world's leading advertisers, Investor Elliott Management buys tiny stake in Wipro[more]

    Hedge funds amass big bets against world's leading advertisers From Hedge funds have amassed bearish bets of more than $3bn against the world's largest advertising companies in an attempt to profit as the industry undergoes ongoing wrenching disruption and slowing growth. Funds i

  3. News Briefs - Investcorp to launch a $100 million PE fund for Omani pension funds[more]

    Bahrain-based investment firm Investcorp will soon launch a $100 million fund dedicated to Oman's Pension Funds as part of its investment plan. 'The Opportunities Fund' will be focused on private equity investments in the U.S. and Europe and will target mid-sized companies across a broad range of se

  4. DoubleLine's Gundlach sees U.S. 10-year Treasury yield rising, weighing on stocks[more]

    From Reuters/ Jeffrey Gundlach, the chief executive of DoubleLine Capital and known on Wall Street as the "Bond King," said on Tuesday the yield on the U.S. 10-year Treasury note will likely move higher and pressure riskier assets including equities and junk bonds. Gundlach, on an

  5. SEC charges Theranos CEO Holmes with fraud[more]

    Bailey McCann, Opalesque New York: The SEC has charged Elizabeth Holmes, founder and CEO of Theranos and its former President Ramesh "Sunny" Balwani with raising more than $700 million from investors through an elaborate, years-long fraud in which they exaggerated or made false statements about t